A detailed history of Tiaa, Fsb transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tiaa, Fsb holds 132,199 shares of BMY stock, worth $7.64 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
132,199
Previous 131,884 0.24%
Holding current value
$7.64 Million
Previous $9.14 Million 7.51%
% of portfolio
0.03%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $20,068 - $22,283
315 Added 0.24%
132,199 $8.45 Million
Q1 2023

Apr 19, 2023

SELL
$65.71 - $74.53 $432,306 - $490,332
-6,579 Reduced 4.75%
131,884 $9.14 Million
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $502,437 - $594,957
-7,337 Reduced 5.03%
138,463 $9.96 Million
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $47 - $28,046
-365 Reduced 0.25%
145,800 $10.4 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $661,422 - $728,457
-9,108 Reduced 5.87%
146,165 $11.3 Million
Q1 2022

Apr 13, 2022

SELL
$61.48 - $73.72 $419,478 - $502,991
-6,823 Reduced 4.21%
155,273 $11.3 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $806,219 - $939,863
-15,033 Reduced 8.49%
162,096 $10.1 Million
Q3 2021

Oct 14, 2021

BUY
$59.17 - $69.31 $84,435 - $98,905
1,427 Added 0.81%
177,129 $10.5 Million
Q2 2021

Jul 21, 2021

SELL
$61.91 - $67.42 $7.53 Million - $8.2 Million
-121,586 Reduced 40.9%
175,702 $11.7 Million
Q1 2021

Apr 21, 2021

SELL
$59.34 - $66.74 $12.9 Million - $14.5 Million
-217,800 Reduced 42.28%
297,288 $18.8 Million
Q4 2020

Jan 21, 2021

BUY
$57.74 - $65.43 $106,414 - $120,587
1,843 Added 0.36%
515,088 $32 Million
Q3 2020

Oct 13, 2020

BUY
$57.43 - $63.64 $1.47 Million - $1.63 Million
25,582 Added 5.25%
513,245 $30.9 Million
Q2 2020

Jul 15, 2020

BUY
$54.82 - $64.09 $5.15 Million - $6.02 Million
93,987 Added 23.87%
487,663 $28.7 Million
Q1 2020

Apr 21, 2020

BUY
$46.4 - $67.43 $1.27 Million - $1.85 Million
27,458 Added 7.5%
393,676 $21.9 Million
Q4 2019

Jan 13, 2020

BUY
$49.21 - $64.19 $5.64 Million - $7.35 Million
114,574 Added 45.53%
366,218 $23.5 Million
Q3 2019

Oct 08, 2019

BUY
$42.77 - $50.71 $5.95 Million - $7.06 Million
139,142 Added 123.68%
251,644 $12.8 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $426,031 - $471,098
-9,548 Reduced 7.82%
112,502 $5.1 Million
Q1 2019

Apr 15, 2019

BUY
$45.12 - $53.8 $141,406 - $168,609
3,134 Added 2.64%
122,050 $5.82 Million
Q4 2018

Apr 15, 2019

BUY
$48.76 - $63.23 $5.8 Million - $7.52 Million
118,916 New
118,916 $6.18 Million
Q4 2018

Feb 22, 2019

SELL
$48.76 - $63.23 $5.78 Million - $7.5 Million
-118,566 Closed
0 $0
Q3 2018

Oct 18, 2018

SELL
$55.19 - $62.25 $22,903 - $25,833
-415 Reduced 0.35%
118,566 $7.36 Million
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $109,447 - $136,414
-2,166 Reduced 1.79%
118,981 $6.59 Million
Q1 2018

Apr 18, 2018

SELL
$59.92 - $68.98 $325,485 - $374,699
-5,432 Reduced 4.29%
121,147 $7.66 Million
Q4 2017

Jan 29, 2018

BUY
$59.94 - $65.35 $731,687 - $797,727
12,207 Added 10.67%
126,579 $7.76 Million
Q3 2017

Oct 24, 2017

BUY
$55.23 - $63.74 $6.32 Million - $7.29 Million
114,372
114,372 $7.29 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tiaa, Fsb Portfolio

Follow Tiaa, Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.